Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.83 0.01  (0.35%)
TradingVolume：755.9
12-12
2025
DISCLOSEABLE TRANSACTION COMPLETION OF THE ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
Publisher：
12-07
2025
VOLUNTARY ANNOUNCEMENT THE GROUP'S FIVE NEW PRODUCTS INCLUDED IN CHINA'S 2025 NATIONAL REIMBURSEMENT DRUG LIST OR COMMERCIAL INSURANCE INNOVATIVE DRUG LIST
Publisher：
12-03
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Publisher：
11-24
2025
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03017 FOR CLINICAL TRIALS IN THE U.S.
Publisher：
11-21
2025
DISCLOSEABLE TRANSACTION ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
Publisher：
11-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Publisher：
10-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Publisher：
09-29
2025
Interim Report 2025
Publisher：
09-10
2025
Next Day Disclosure Return
Publisher：
09-10
2025
OVERSEAS REGULATORY ANNOUNCEMENT
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：755.9
2.83
0.01  (0.35%)
Announcement & Circular
12-12
2025
DISCLOSEABLE TRANSACTION COMPLETION OF THE ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
12-07
2025
VOLUNTARY ANNOUNCEMENT THE GROUP'S FIVE NEW PRODUCTS INCLUDED IN CHINA'S 2025 NATIONAL REIMBURSEMENT DRUG LIST OR COMMERCIAL INSURANCE INNOVATIVE DRUG LIST
12-03
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
11-24
2025
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03017 FOR CLINICAL TRIALS IN THE U.S.
11-21
2025
DISCLOSEABLE TRANSACTION ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
11-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
10-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
09-29
2025
Interim Report 2025
09-10
2025
Next Day Disclosure Return
09-10
2025
OVERSEAS REGULATORY ANNOUNCEMENT
First
1
2
3
4
5
Last